{"entity":{"type":"insider","cik":"0001290747","url":"/insider/0001290747","json_url":"/insider/0001290747.json","name":"McMahon Gerald PhD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":7,"first":"2004-05-26","last":"2019-05-16","span_basis":"filed_date"},"name_variants":[{"name":"McMahon Gerald PhD","source":"filing","n_filings":7,"first_seen":"2004-05-26","last_seen":"2019-05-16"}],"transactions":[{"id":8566730,"accession":"0001209191-19-030200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-030200","line_url":"/filing/0001209191-19-030200#line-1","is_derivative":false,"issuer_cik":"0001290747","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001290747","owner_cik":"0001290747","owner_name":"McMahon Gerald PhD","owner_display_name":"McMahon Gerald PhD","owner_url":"/insider/0001290747","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":10.1573,"price_display":"10.16","price_state":"stated","total_value":10157.3,"total_display":"10,157.30","total_whole":"10,157","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-14","filed_date":"2019-05-16","scope":"insider"},{"id":8204165,"accession":"0001209191-19-028675","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-028675","line_url":"/filing/0001209191-19-028675#line-1","is_derivative":false,"issuer_cik":"0001290747","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001290747","owner_cik":"0001290747","owner_name":"McMahon Gerald PhD","owner_display_name":"McMahon Gerald PhD","owner_url":"/insider/0001290747","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":10.5587,"price_display":"10.56","price_state":"stated","total_value":10558.7,"total_display":"10,558.70","total_whole":"10,559","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-08","filed_date":"2019-05-10","scope":"insider"},{"id":8345276,"accession":"0001209191-19-027964","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-027964","line_url":"/filing/0001209191-19-027964#line-1","is_derivative":false,"issuer_cik":"0001290747","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001290747","owner_cik":"0001290747","owner_name":"McMahon Gerald PhD","owner_display_name":"McMahon Gerald PhD","owner_url":"/insider/0001290747","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":10.53,"price_display":"10.53","price_state":"stated","total_value":10530.0,"total_display":"10,530.00","total_whole":"10,530","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-03","filed_date":"2019-05-07","scope":"insider"},{"id":3955972,"accession":"0001179110-08-021647","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-08-021647","line_url":"/filing/0001179110-08-021647","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001290747","owner_name":"McMahon Gerald PhD","owner_display_name":"McMahon Gerald PhD","owner_url":"/insider/0001290747","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":1.2942666666666667,"price_display":"1.29","price_state":"stated","total_value":9707.0,"total_display":"9,707.00","total_whole":"9,707","shares_owned_after":19608.0,"shares_owned_after_display":"19,608","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-30","filed_date":"2008-12-31","scope":"insider","n_lines":4},{"id":3514900,"accession":"0001179110-08-021607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-08-021607","line_url":"/filing/0001179110-08-021607#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001290747","owner_name":"McMahon Gerald PhD","owner_display_name":"McMahon Gerald PhD","owner_url":"/insider/0001290747","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7375.0,"shares_display":"7,375","price_per_share":1.4,"price_display":"1.40","price_state":"stated","total_value":10325.0,"total_display":"10,325.00","total_whole":"10,325","shares_owned_after":12108.0,"shares_owned_after_display":"12,108","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-29","filed_date":"2008-12-30","scope":"insider"},{"id":3447216,"accession":"0001179110-08-005383","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-08-005383","line_url":"/filing/0001179110-08-005383#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001290747","owner_name":"McMahon Gerald PhD","owner_display_name":"McMahon Gerald PhD","owner_url":"/insider/0001290747","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3900.0,"shares_display":"3,900","price_per_share":3.93,"price_display":"3.93","price_state":"stated","total_value":15327.0,"total_display":"15,327.00","total_whole":"15,327","shares_owned_after":4733.0,"shares_owned_after_display":"4,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-06","filed_date":"2008-03-07","scope":"insider"},{"id":297859,"accession":"0001179110-04-011516","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-04-011516","line_url":"/filing/0001179110-04-011516#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"NEORX CORP","issuer_ticker":"NERX","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001290747","owner_name":"McMahon Gerald PhD","owner_display_name":"McMahon Gerald PhD","owner_url":"/insider/0001290747","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"NeoRx Corporation Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":13750.0,"total_display":"13,750.00","total_whole":"13,750","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-25","filed_date":"2004-05-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001708493","name":"Harpoon Therapeutics, Inc.","url":"/issuer/0001708493","role":"Director, Officer (President and CEO)","n_filings":3,"first_seen":"2019-05-07","last_seen":"2019-05-16"},{"type":"issuer","type_label":"ISSUER","cik":"0000755806","name":"PONIARD PHARMACEUTICALS, INC.","url":"/issuer/0000755806","role":"Director, Officer (Chief Executive Officer)","n_filings":4,"first_seen":"2004-05-26","last_seen":"2008-12-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001290747","retrieved_at":"2026-08-22T10:44:45+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}